Overcoming Drug Resistance in Liver Cancer
Sorafenib is a first-line therapy used to treat advanced liver cancer, but its effectiveness is often reduced due to resistance in cancer cells. This study co-led by N2CR member, A/Prof […]
Day: August 31, 2025